Deltawave(TM) Launch Plan

REMSleep Announces Strategic launch of the Deltawave™ CPAP Mask System

BLACKSHEAR, GA / ACCESS Newswire / October 1, 2025 / RemSleep Holdings, Inc. (OTCID:RMSL) Remsleep, the developer of the FDA-Cleared Deltawave CPAP mask system gives shareholder update on progress and status of Deltawave launch.

Remsleep has finalized contracts with independent sales reps covering the entire US. Remsleep is presently developing an instructional video for sales reps. The video is expected to be completed by the end of this week. VGM has been developing a trifold brochure for sales reps and is expected to be completed by the end of this week. Sales reps have been waiting on Remsleep to get adequate inventory for fulfillment to satisfy DME and customer needs. Fulfillment inventory has arrived at Remsleep and looks very good!

Remsleep is currently in the process of evaluating an ERP ( Enterprise Resource Planning) system that will keep inventory, in transit inventory, accounting, CRM, PO generation, and collection, order entry and returns, customer billing, quality management, sales reporting and business analytics. The system is critical to the growth of the company.

This is all taking longer than we expected and has truly been an incredible learning experience. We hope shareholders can appreciate we are being very careful to do things the right way, which usually is more difficult and takes more time. Remsleep CEO Tom Wood say’s “I apologize for not communicating more often to shareholders. The company has been caught up with trying to get company business running well and it has been very distracting. I sincerely hope in the next few days we will get the traction we have been working towards and meet the needs of those we will serve.”

Deltawave™, created by RemSleep is a patented CPAP interface designed to restore natural breathing rhythms without pressure resistance, facial strain, or humidification. It’s already gaining traction among users, and clinicians seeking non-invasive alternatives.

CONTACT:

Tom Wood
912-590-2001
twood@remsleep.com

SOURCE: RemSleep Holdings, Inc.

View the original press release on ACCESS Newswire

Staff

Recent Posts

Lightera Advances Fiber-integrated Temperature Feedback for Safer Laser-based Medical Procedures

SAN FRANCISCO, Jan. 16, 2026 /PRNewswire/ -- BiOS - Hall D Booth #8430, Photonics West Hall…

15 hours ago

DiagnosTear Announces Interim Clinical Results Indicating High Efficiency from TeaRx(TM) Red Eye

Vancouver, British Columbia--(Newsfile Corp. - January 16, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE:…

20 hours ago

NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…

21 hours ago

University of Phoenix and LinkedIn to host webinar on AI in nursing with skills and strategies for a new era of healthcare

January 22 virtual event "AI in Action: Skills and Strategies for a New Era of…

21 hours ago

Instinct Science Acquires ScribbleVet to Deliver the Next Generation of Intelligent-Native Veterinary Practice Management Software

The combination redefines PIMS by embedding AI, workflow, and clinical intelligence into a single system…

21 hours ago

Hemostemix Receives FDA Support for Its Basket Protocol Approach

Calgary, Alberta--(Newsfile Corp. - January 16, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…

1 day ago